Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention
The aim of this study was to investigate the long-term clinical impact of residual inflammatory risk (RIR) by evaluating serial high-sensitivity C-reactive protein (hs-CRP) in Asian patients with coronary artery disease (CAD). We evaluated 2032 patients with stable CAD undergoing percutaneous corona...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/4/1033 |
id |
doaj-951fbbb6366f46c2a8730c7846cfc962 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Norihito Takahashi Tomotaka Dohi Hirohisa Endo Takehiro Funamizu Hideki Wada Shinichiro Doi Yoshiteru Kato Manabu Ogita Iwao Okai Hiroshi Iwata Shinya Okazaki Kikuo Isoda Katsumi Miyauchi Kazunori Shimada |
spellingShingle |
Norihito Takahashi Tomotaka Dohi Hirohisa Endo Takehiro Funamizu Hideki Wada Shinichiro Doi Yoshiteru Kato Manabu Ogita Iwao Okai Hiroshi Iwata Shinya Okazaki Kikuo Isoda Katsumi Miyauchi Kazunori Shimada Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention Journal of Clinical Medicine hs-CRP residual risk biomarker inflammation coronary artery disease percutaneous coronary intervention |
author_facet |
Norihito Takahashi Tomotaka Dohi Hirohisa Endo Takehiro Funamizu Hideki Wada Shinichiro Doi Yoshiteru Kato Manabu Ogita Iwao Okai Hiroshi Iwata Shinya Okazaki Kikuo Isoda Katsumi Miyauchi Kazunori Shimada |
author_sort |
Norihito Takahashi |
title |
Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention |
title_short |
Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention |
title_full |
Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention |
title_fullStr |
Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention |
title_full_unstemmed |
Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention |
title_sort |
residual inflammation indicated by high-sensitivity c-reactive protein predicts worse long-term clinical outcomes in japanese patients after percutaneous coronary intervention |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2020-04-01 |
description |
The aim of this study was to investigate the long-term clinical impact of residual inflammatory risk (RIR) by evaluating serial high-sensitivity C-reactive protein (hs-CRP) in Asian patients with coronary artery disease (CAD). We evaluated 2032 patients with stable CAD undergoing percutaneous coronary intervention (PCI) with serial hs-CRP measurements (2 measurements, 6–9 months apart) from the period 2000 to 2016. A high-RIR was defined as hs-CRP > 0.9 mg/L according to the median value. Patients were assigned to four groups: persistent-high-RIR, increased-RIR, attenuated-RIR, or persistent-low-RIR. Major adverse cardiac events (MACE) and all-cause death were evaluated. MACE rates in patients with persistent high, increased and attenuated RIR were significantly higher than in patients with persistent low RIR (<i>p</i> < 0.001). Moreover, the rate of all-cause death was significantly higher among patients with persistent high and increased RIR than among patients with attenuated and persistent low RIR (<i>p</i> < 0.001). After adjustment, the presence of persistent high RIR (hazard ratio (HR) 2.22; 95% confidence interval (CI) 1.37–3.67, <i>p</i> = 0.001), increased RIR (HR 2.25, 95%CI 1.09–4.37, <i>p</i> = 0.029), and attenuated RIR (HR 1.94, 95%CI 1.14–3.32, <i>p</i> = 0.015) were predictive for MACE. In addition, presence of persistent high RIR (HR 2.07, 95%CI 1.41–3.08, <i>p</i> < 0.001) and increased RIR (HR 1.94, 95%CI 1.07–3.36, <i>p</i> = 0.029) were predictive for all-cause death. A high RIR was significantly associated with MACE and all-cause death among Japanese CAD patients. An evaluation of changes in inflammation may carry important prognostic information and may guide the therapeutic approach. |
topic |
hs-CRP residual risk biomarker inflammation coronary artery disease percutaneous coronary intervention |
url |
https://www.mdpi.com/2077-0383/9/4/1033 |
work_keys_str_mv |
AT norihitotakahashi residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT tomotakadohi residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT hirohisaendo residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT takehirofunamizu residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT hidekiwada residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT shinichirodoi residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT yoshiterukato residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT manabuogita residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT iwaookai residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT hiroshiiwata residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT shinyaokazaki residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT kikuoisoda residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT katsumimiyauchi residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention AT kazunorishimada residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention |
_version_ |
1724864320837255168 |
spelling |
doaj-951fbbb6366f46c2a8730c7846cfc9622020-11-25T02:21:57ZengMDPI AGJournal of Clinical Medicine2077-03832020-04-0191033103310.3390/jcm9041033Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary InterventionNorihito Takahashi0Tomotaka Dohi1Hirohisa Endo2Takehiro Funamizu3Hideki Wada4Shinichiro Doi5Yoshiteru Kato6Manabu Ogita7Iwao Okai8Hiroshi Iwata9Shinya Okazaki10Kikuo Isoda11Katsumi Miyauchi12Kazunori Shimada13Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiology, Juntendo University Shizuoka Hospital, 1129 nagaoka, Izunokuni-shi 410-2295, Shizuoka, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiology, Juntendo University Shizuoka Hospital, 1129 nagaoka, Izunokuni-shi 410-2295, Shizuoka, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanThe aim of this study was to investigate the long-term clinical impact of residual inflammatory risk (RIR) by evaluating serial high-sensitivity C-reactive protein (hs-CRP) in Asian patients with coronary artery disease (CAD). We evaluated 2032 patients with stable CAD undergoing percutaneous coronary intervention (PCI) with serial hs-CRP measurements (2 measurements, 6–9 months apart) from the period 2000 to 2016. A high-RIR was defined as hs-CRP > 0.9 mg/L according to the median value. Patients were assigned to four groups: persistent-high-RIR, increased-RIR, attenuated-RIR, or persistent-low-RIR. Major adverse cardiac events (MACE) and all-cause death were evaluated. MACE rates in patients with persistent high, increased and attenuated RIR were significantly higher than in patients with persistent low RIR (<i>p</i> < 0.001). Moreover, the rate of all-cause death was significantly higher among patients with persistent high and increased RIR than among patients with attenuated and persistent low RIR (<i>p</i> < 0.001). After adjustment, the presence of persistent high RIR (hazard ratio (HR) 2.22; 95% confidence interval (CI) 1.37–3.67, <i>p</i> = 0.001), increased RIR (HR 2.25, 95%CI 1.09–4.37, <i>p</i> = 0.029), and attenuated RIR (HR 1.94, 95%CI 1.14–3.32, <i>p</i> = 0.015) were predictive for MACE. In addition, presence of persistent high RIR (HR 2.07, 95%CI 1.41–3.08, <i>p</i> < 0.001) and increased RIR (HR 1.94, 95%CI 1.07–3.36, <i>p</i> = 0.029) were predictive for all-cause death. A high RIR was significantly associated with MACE and all-cause death among Japanese CAD patients. An evaluation of changes in inflammation may carry important prognostic information and may guide the therapeutic approach.https://www.mdpi.com/2077-0383/9/4/1033hs-CRPresidual riskbiomarkerinflammationcoronary artery diseasepercutaneous coronary intervention |